148 related articles for article (PubMed ID: 28721446)
1. Rhamnolipids Enhance in Vivo Oral Bioavailability of Poorly Absorbed Molecules.
Khafagy ES; El-Azab MF; ElSayed MEH
Pharm Res; 2017 Oct; 34(10):2197-2210. PubMed ID: 28721446
[TBL] [Abstract][Full Text] [Related]
2. Effect of rhamnolipids on permeability across Caco-2 cell monolayers.
Wallace CJ; Medina SH; ElSayed ME
Pharm Res; 2014 Apr; 31(4):887-94. PubMed ID: 24065598
[TBL] [Abstract][Full Text] [Related]
3. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
Hamid KA; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2009 Sep; 379(1):100-8. PubMed ID: 19555752
[TBL] [Abstract][Full Text] [Related]
4. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
5. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral delivery of alendronate by sucrose fatty acids esters in rats and their absorption-enhancing mechanisms.
Alama T; Katayama H; Hirai S; Ono S; Kajiyama A; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2016 Dec; 515(1-2):476-489. PubMed ID: 27793710
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
8. [Improvement of intestinal absorption of poorly absorbable drugs by various sugar esters].
Yamamoto A; Katsumi H; Kusamori K; Sakane T
Yakugaku Zasshi; 2014; 134(1):47-53. PubMed ID: 24389617
[TBL] [Abstract][Full Text] [Related]
9. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
10. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
11. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.
Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2016 Feb; 499(1-2):58-66. PubMed ID: 26707414
[TBL] [Abstract][Full Text] [Related]
12. The characteristics and mechanism of co-administration of lovastatin solid dispersion with kaempferol to increase oral bioavailability.
Li J; Di L; Cheng X; Ji W; Piao H; Cheng G; Zou M
Xenobiotica; 2020 May; 50(5):593-601. PubMed ID: 31505985
[TBL] [Abstract][Full Text] [Related]
13. Changes in protein and mRNA expression levels of claudin family after mucosal lesion by intestinal ischemia/reperfusion.
Takizawa Y; Kishimoto H; Kitazato T; Tomita M; Hayashi M
Int J Pharm; 2012 Apr; 426(1-2):82-89. PubMed ID: 22285474
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
15. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
Wang X; Maher S; Brayden DJ
Ther Deliv; 2010 Jul; 1(1):75-82. PubMed ID: 22816121
[TBL] [Abstract][Full Text] [Related]
16. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
Onishi H; Imura Y; Uchida M; Machida Y
Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
[TBL] [Abstract][Full Text] [Related]
17. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L.
Xie Y; Luo H; Duan J; Hong C; Ma P; Li G; Zhang T; Wu T; Ji G
Fitoterapia; 2014 Mar; 93():216-25. PubMed ID: 24462958
[TBL] [Abstract][Full Text] [Related]
18. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
19. Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat.
Yan C; Gu J; Lv Y; Shi W; Jing H
Drug Deliv Transl Res; 2017 Jun; 7(3):408-415. PubMed ID: 28303451
[TBL] [Abstract][Full Text] [Related]
20. Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.
Jiang L; Long X; Meng Q
Int J Pharm; 2013 Mar; 446(1-2):130-5. PubMed ID: 23402975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
